What about using a non-viral transfection method that achieves up to 80% transfection efficiency and high expression levels?


For almost a decade the Amaxa™ Nucleofector™ Technology has proven to be the method of choice for non-viral transfection of hard-to-transfect cell types. A unique combination of electrical parameters, cell-type specific Nucleofector™ Kits and Optimized Protocols helps to achieve immediate transfection success in virtually any cell type.

  • Over 30 respiratory and cardiovascular primary cell and cell line protocols and kits available for a quick route to optimal results
  • High efficiencies and viabilities paired with preservation of cell functionality Different device platforms for different cell numbers and throughput options
  • NEW: 4D-Nucleofector™ allows transfection of 2x104 to 2x107 cells with same protocol and with up to 16 reactions in parallel  


Transfection of Primary Cardiovascular & Respiratory Cells
Examples of Nucleofection™ Results for cells from cardiovascular or respiratory tissue.
All cells marked with * are Lonza Clonetics™ Cells and have been validated to work with Nucleofector™ Technology.



To check your cell type of interest please visit our cell database or refer to our Nucleofector™ Kits for primary cells or cell lines.